News & Events

They develop a vaccine against multiple sclerosis with modified material from the coronavirus vaccine.

January 12, 2021

They develop a vaccine against multiple sclerosis with modified material from the coronavirus vaccine. The German company BioNTech has tested it successfully in mice without causing immunosuppression. Mabel Fajardo reports.
Share